Inhaled corticosteroids vs no treatment or placebo
- Postnatal corticosteroids for transient tachypnoea of the newborn 2020 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether targeted or adjustable individualized fortification changes bronchopulmonary dysplasia compared with standard non‐individualized fortification (very low certainty).
Strategies to increase use of antenatal corticosteroids probably leads to higher perinatal death (at population level) compared with routine (usual) care (moderate certainty).
Strategies to increase use of antenatal corticosteroids probably leads to higher neonatal death before 28 days (at population level) compared with routine (usual) care (moderate certainty).
Strategies to increase use of antenatal corticosteroids probably leads to higher stillbirth (at population level) compared with routine (usual) care (moderate certainty).
Strategies to increase use of antenatal corticosteroids may leads to higher maternal infection or inflammation (at population level) compared with routine (usual) care (low certainty).
Strategies to increase use of antenatal corticosteroids showed no clear difference in maternal mortality (at population level) compared with routine (usual) care (low certainty).
The intervention probably leads to lower treatment discontinuation due to adverse event (safety population) (moderate certainty).
The intervention may leads to higher treatment‐related death (safety population) (low certainty).
The intervention may leads to higher nausea/vomiting* grade 3 or 4 (safety population) (low certainty).
The review found no eligible studies for this question.
The intervention may leads to higher anaemia grade 3 or 4 (safety population) (low certainty).
The intervention may leads to lower hair loss (safety population) (low certainty).
The intervention probably leads to higher leukopaenia (safety population) (moderate certainty).
Inositol supplementation to preterm infants (repeat doses in any… showed no clear difference in bronchopulmonary dysplasia (at 36 to 38 weeks' PMA) compared with control (moderate certainty).
Incentives leads to higher smoking cessation in mixed populations ‐ Longest compared with no incentives (high certainty).
The review found no eligible studies for this question.